BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18449570)

  • 1. Antimicrobial chlorhexidine/silver sulfadiazine-coated central venous catheters versus those uncoated in patients undergoing allogeneic stem cell transplantation.
    Vokurka S; Kabatova-Maxova K; Skardova J; Bystricka E
    Support Care Cancer; 2009 Feb; 17(2):145-51. PubMed ID: 18449570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
    Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M
    Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of chlorhexidine-silver sulfadiazine impregnated central venous catheters in patients receiving high-dose chemotherapy followed by peripheral stem cell transplantation.
    Maaskant JM; De Boer JP; Dalesio O; Holtkamp MJ; Lucas C
    Eur J Cancer Care (Engl); 2009 Sep; 18(5):477-82. PubMed ID: 19453696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized trial of an antibiotic- and antiseptic-coated central venous catheter in the prevention of catheter-related infections.
    Tennenberg S; Lieser M; McCurdy B; Boomer G; Howington E; Newman C; Wolf I
    Arch Surg; 1997 Dec; 132(12):1348-51. PubMed ID: 9403542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial.
    Brun-Buisson C; Doyon F; Sollet JP; Cochard JF; Cohen Y; Nitenberg G
    Intensive Care Med; 2004 May; 30(5):837-43. PubMed ID: 15060765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients--a double-blind, randomised, prospective, controlled trial.
    Ostendorf T; Meinhold A; Harter C; Salwender H; Egerer G; Geiss HK; Ho AD; Goldschmidt H
    Support Care Cancer; 2005 Dec; 13(12):993-1000. PubMed ID: 15834740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.
    Schuerer DJ; Zack JE; Thomas J; Borecki IB; Sona CS; Schallom ME; Venker M; Nemeth JL; Ward MR; Verjan L; Warren DK; Fraser VJ; Mazuski JE; Boyle WA; Buchman TG; Coopersmith CM
    Surg Infect (Larchmt); 2007 Aug; 8(4):445-54. PubMed ID: 17883361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia.
    Heard SO; Wagle M; Vijayakumar E; McLean S; Brueggemann A; Napolitano LM; Edwards LP; O'Connell FM; Puyana JC; Doern GV
    Arch Intern Med; 1998 Jan; 158(1):81-7. PubMed ID: 9437382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients.
    Carrasco MN; Bueno A; de las Cuevas C; Jimenez S; Salinas I; Sartorius A; Recio T; Generelo M; Ruiz-Ocaña F
    Intensive Care Med; 2004 Apr; 30(4):633-8. PubMed ID: 14722639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of catheter-related blood stream infection: back to basics?
    Cherry-Bukowiec JR; Denchev K; Dickinson S; Chenoweth CE; Zalewski C; Meldrum C; Sihler KC; Brunsvold ME; Papadimos TJ; Park PK; Napolitano LM
    Surg Infect (Larchmt); 2011 Feb; 12(1):27-32. PubMed ID: 21171811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central venous catheter colonization in critically ill patients: a prospective, randomized, controlled study comparing standard with two antiseptic-impregnated catheters.
    Dünser MW; Mayr AJ; Hinterberger G; Flörl CL; Ulmer H; Schmid S; Friesenecker B; Lorenz I; Hasibeder WR
    Anesth Analg; 2005 Dec; 101(6):1778-1784. PubMed ID: 16301258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project.
    Collin GR
    Chest; 1999 Jun; 115(6):1632-40. PubMed ID: 10378561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial.
    Rupp ME; Lisco SJ; Lipsett PA; Perl TM; Keating K; Civetta JM; Mermel LA; Lee D; Dellinger EP; Donahoe M; Giles D; Pfaller MA; Maki DG; Sherertz R
    Ann Intern Med; 2005 Oct; 143(8):570-80. PubMed ID: 16230723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.
    Maki DG; Stolz SM; Wheeler S; Mermel LA
    Ann Intern Med; 1997 Aug; 127(4):257-66. PubMed ID: 9265424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-infective external coating of central venous catheters: a randomized, noninferiority trial comparing 5-fluorouracil with chlorhexidine/silver sulfadiazine in preventing catheter colonization.
    Walz JM; Avelar RL; Longtine KJ; Carter KL; Mermel LA; Heard SO;
    Crit Care Med; 2010 Nov; 38(11):2095-102. PubMed ID: 20711070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial.
    Logghe C; Van Ossel C; D'Hoore W; Ezzedine H; Wauters G; Haxhe JJ
    J Hosp Infect; 1997 Oct; 37(2):145-56. PubMed ID: 9364263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central venous catheters revisited--infection rates and an assessment of the new Fibrin Analysing System brush.
    van Heerden PV; Webb SA; Fong S; Golledge CL; Roberts BL; Thompson WR
    Anaesth Intensive Care; 1996 Jun; 24(3):330-3. PubMed ID: 8805887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New choices for central venous catheters: potential financial implications.
    Shorr AF; Humphreys CW; Helman DL
    Chest; 2003 Jul; 124(1):275-84. PubMed ID: 12853534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of prolonging the use of central venous catheters: a prospective analysis of the effects of using antiseptic-bonded catheters with daily site care.
    Norwood S; Wilkins HE; Vallina VL; Fernandez LG; McLarty JW
    Crit Care Med; 2000 May; 28(5):1376-82. PubMed ID: 10834681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of central venous catheter type on infections: a prospective clinical trial.
    Richards B; Chaboyer W; Bladen T; Schluter PJ
    J Hosp Infect; 2003 May; 54(1):10-7. PubMed ID: 12767841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.